<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Palkowski L</submitter><funding>Nicolaus Copernicus University</funding><pagination>1974</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8953206</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(6)</volume><pubmed_abstract>In this study, a series of 10 novel 1-methyl-3-octyloxymethylimidazolium derivatives carrying various anionic moieties (4-hydroxybenzenesulfonate, benzenesulfonate, carvacroloxyacetate, chloride, formate, propionate, thymoloxyacetate, vanillinoxyacetate, eugenoloxyacetate and trimethylacetate) were synthesized. Compounds were tested for their antimicrobial activity against six microbe strains (Staph-ylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterococcus faecalis, and Candida albicans), cytotoxic activity against the mouse melanoma cell line (B16 F10), and surface active properties. All synthesized compounds exhibited antimicrobial activity (expressed as minimum inhibitory concentration; in range of 0.10-27.82 mM/L), especially against Gram-positive </pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Antimicrobial and Cytotoxic Activity of Novel Imidazolium-Based Ionic Liquids.</pubmed_title><pmcid>PMC8953206</pmcid><funding_grant_id>44-IDUB 2020-1 NZ PAŁKOWSKI</funding_grant_id><pubmed_authors>Wojcieszak M</pubmed_authors><pubmed_authors>Walkiewicz F</pubmed_authors><pubmed_authors>Jaroch K</pubmed_authors><pubmed_authors>Skrzypczak A</pubmed_authors><pubmed_authors>Palkowski L</pubmed_authors><pubmed_authors>Materna K</pubmed_authors><pubmed_authors>Krysinski J</pubmed_authors><pubmed_authors>Karolak M</pubmed_authors><pubmed_authors>Bojko B</pubmed_authors><pubmed_authors>Podemski J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Antimicrobial and Cytotoxic Activity of Novel Imidazolium-Based Ionic Liquids.</name><description>In this study, a series of 10 novel 1-methyl-3-octyloxymethylimidazolium derivatives carrying various anionic moieties (4-hydroxybenzenesulfonate, benzenesulfonate, carvacroloxyacetate, chloride, formate, propionate, thymoloxyacetate, vanillinoxyacetate, eugenoloxyacetate and trimethylacetate) were synthesized. Compounds were tested for their antimicrobial activity against six microbe strains (Staph-ylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterococcus faecalis, and Candida albicans), cytotoxic activity against the mouse melanoma cell line (B16 F10), and surface active properties. All synthesized compounds exhibited antimicrobial activity (expressed as minimum inhibitory concentration; in range of 0.10-27.82 mM/L), especially against Gram-positive </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-19T13:21:00.856Z</modification><creation>2025-04-19T13:21:00.856Z</creation></dates><accession>S-EPMC8953206</accession><cross_references><pubmed>35335335</pubmed><doi>10.3390/molecules27061974</doi></cross_references></HashMap>